share_log

东瑞制药(02348.HK)获非执行董事梁康民增持50万股

Dong Rui Pharmaceutical (02348.HK) gets 500000 shares increased by non-executive director Liang Kangmin

Gelonghui Finance ·  Jun 30, 2022 08:10

Gronghui APP was informed that according to the latest equity disclosure information of the Stock Exchange, on June 27th, 2022, East Rui Pharmaceutical (02348.HK) was increased by non-executive director Liang Kangmin to hold 500000 shares at an average price of HK $1.2833 per share, involving a capital of about HK $641650.

After the increase, Liang Kangmin's latest number of shares is 107112000 shares, with the proportion of shares rising from 7.11% to 7.15%.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment